Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

MSL Talk

MSL Talk artwork

The Value of Social Listening for MSL Success

Sep 10, 202430 minAudio
ShareXLinkedInFacebookWhatsAppEmail

My guests this week are Vandana Grover, Sr Director, Head of Digital Strategy and Innovation at Eisai and Stevan Tomich, Lead Omni Channel Strategist at AbbVie who discuss the value of social listening for MSL success.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

Guys. Welcome to the podcast. My guests today are Vandana Grover, senior director head of digital strategy and innovation at Eisai, and Steve Tomich, lead omnichannel strategist at AbbVie. And we discuss the value of social listening for MSL success. Great conversation. This is one of those episodes where I know you guys are gonna wanna take notes, and you're definitely gonna wanna share it with others. So thank you for joining us, and we appreciate all of your support for this show.

Welcome to MSL talk with Tom Caravella, a podcast specifically designed for MSLs and all things field medical. Okay. Stevan Bandana, how are you guys? Welcome to the podcast. Doing well. Thank you. Yeah. Glad to be here. Yeah. Guys, super excited about this. This is, I think you guys are gonna love this topic. We're gonna talk about social listening. And the reason social listening has come up is because we have a very special sponsor for this

episode, and that sponsor is Medical Watch. So I don't know if you're familiar, but Medical Watch helps you understand what HCPs are saying about your products and diseases on social media. So guys, you're always asking me for resources and I'm always getting messages about what resources. Medical Watch is definitely a resource you guys should register for. So if you go to medical dot watch, you can sign up for free. So check this out.

Definitely an important resource. So before we get into the social listening topic, why don't we do some introductions? Vandana, why don't you go first? Yeah. Thanks again for the invite, Tom. Pleasure to be here. So I'm the senior director for digital strategy and innovation for global and US medical affairs at Eisai. And just a caveat throwing it out there so we can get this out of the way, the views I expressed today are my own and do not necessarily reflect the position or views of my employer.

Awesome. Thank you. And, Steph, you go next. Awesome. Hey, everybody. My name's Steph. I'm a pharmacist by training, and I currently work in omnichannel strategy at AbbVie supporting our oncology business unit as well as our specialty business unit. And, similarly, the views expressed are my own and not that of AbbVie Pharmaceuticals. Awesome. Well, guys, this is this is such an important topic, and it's one that comes, well, I shouldn't say it comes up all the time, but I'm always being asked about, what ways we can use

social media and technology within the medical affairs space. So this social listening concept is not one that we've covered yet, so I'm excited to bring it in bring it into this platform. So my first question is, how are successful and social media savvy MSLs going about social listening? So let's start with you, Vandana. Yeah. So I think first is just understanding the importance of social listening, and I think,

you know, we've been hearing about it for a few years. Different groups are doing it in different ways, but it is important and it is relevant. So we wanna make sure that, as an MSL that that they're definitely aware of that. And if you look at some data that's been out there for the last couple of years, some from MAPS, the Medical Affairs Professional Society, it's showing that 37% of physicians under 55 use social networks and about 25% over 55. And a more recent report from, McKinsey shows that 42% of USHCP spend at least 2 hours a day

on social media sites. So there's a pretty good chance that within the MSL's territory, especially if, they are in the US, their HCPs are active on social. And if they're not, maybe actively posting, they are probably reading what other people, and what their colleagues are saying. So I think there are a few different ways that, savvy MSLs go about social listening. It would depend a little bit on how the their company is structured, but you can do it at an individual level.

You follow the active HCPs and those HCPs that are in your territory on the various social channels that they, participate in. You can do it as a department or as a team effort. Maybe there's a specific social listening team that's going through these insights regularly, weekly, for that therapeutic area and putting that together and consolidating that. So maybe you're reading those those reports. And then there are also platforms and tools that if you have access to, they can really

help aggregate those social listening, insights. It's really hard to keep up, I think, with all your HCPs, what everyone's saying on social. So if you can check-in maybe once a week or right before an important, meeting or conference, check one of these platforms or tools out. You could filter by trial name, maybe by product, the HCP's name. So that could help you, also kinda keep up with what is going on, on social channels. I'll tell you. I'm glad you shared statistics because those numbers are higher than I would have thought.

And it's interesting because we I we've talked about this kinda sorta on this podcast, in the past, but it this conversation right now is very different than 4 years ago because those statistics would have been way less. So I think we're coming into a time when social media channels have been adopted. HCPs are out there on social media. It's just becoming a thing. It's like everybody is kind of involved.

So, Steph, what would you say as far as like, what are the most relevant social media channels right now, and where would MSLs need to be listening? Yeah. I would say, first and foremost, you gotta be on Twitter or x because that's where scientific exchange is happening. You know, when I was in MSL, I wanna do my pre call planning. I'd see if anything was published. I'd see if they had spoken at a conference or I remember that recently, that was all planned. That was all staged. That was not what they wanted to say.

Right? This is them saying what they wanna say to the point where it's almost expected in some institutions now that you have an x account just like it's expected you publish a little bit. They want that visibility, not only for the HCP themselves, but for that account itself. And then as age demographics change, you're seeing more and more doctors on TikTok. If it's a visible disease state, no oncology, probably not gonna be on Instagram that much. But let's say you're in the dermatology space, the rheumatology space, people are using those videos and those platforms on Instagram. And then from an institution level, if you're covering, you know, you got that whole

institution in your in your territory, especially if it's one of the biggest in the country, they probably have a YouTube channel, and they probably have a lot of their HCPs on that YouTube channel showing what they care about to their patient. And taking that in besides some additional insights that I can bring back in, but also how I'm gonna make my call. If I thought that, you know, the HCP knew this, but then he explained it on a YouTube video or explained it to another physician differently than how I believe the data goes or what you know, we can have discuss that and go into a little bit more detail and have that ready for that conversation.

Yeah. Because if you miss it, if it's clearly out there and it's obvious and you miss it, you're failing. Right? You're going in and you may be talking about something where I've had MSL say to me, on this podcast, I went in with an agenda, said this, and the and the HCP said to me, well, clearly, you didn't read my article. Clearly, you didn't see my video. Clearly, you didn't this. So that just goes to show how important. But, Vandana, getting back to you, when it comes to this social listening process, is

there, like, a structure that MSLs need to follow, for lack of a better word? Well, you know, I just wanna follow-up on one thing that you mentioned. You know, just like we used to see make sure we looked at their publications. Are they a PI in a clinical trial? Are they, are they presenting at a conference? This is just another place that we also need to look at and make sure we incorporate that in any of the the pre call planning, as Stefan mentioned. So I think in in terms of, structure, again, I think it depends a little bit on how your

organization, is set up. If you don't have any formal structure, I would consider, following HCPs on these channels, all the channels that, Stefan mentioned. And then not just your HCPs that are part of your territory, but also the HCPs that, have a bigger, maybe share of voice. They are digital leaders. Because if one HCP is thinking about something, probably another one may not be active, but it's probably thinking, the same thing or has those similar questions.

I mentioned some of the platforms and tools. Those are also considerations, to kind of add, as a next step. Reading any reports that come out around social listening, even if it's outside of medical affairs. Sometimes you'll get, reports from your business intelligence team. They're also looking at, insights across social channels. So maybe they're picking up something, so make sure that you're you're checking that. And then right before your meeting, I would take a look at that HCP's, profile and see, you

know, did they say something just like you mentioned so it's not it's not missed, and you know what they're what they're thinking about. And then if there's any new data that's just come out, what are people's that's relevant to you and your space? What are people thinking about that? What are they saying? That might give you an idea of some of the questions they may have and help you prep for for your meeting. So as I'm as I'm listening to you guys, 2 things come to mind. I actually had somebody on my podcast, and he said that you need to meet KOLs where they

live. So as I'm as we're talking about it, is it safe to say that each of your HCPs are just gonna have different preferences for where they're gonna hang out and it's your job to find it? Definitely. I have to jump in as the, you know, the omnichannel. That's the that's the whole point. You know, that's the biggest difference between multichannel and omnichannel. Multichannel's being in a lot of places. Omnichannel's knowing that your doctor is gonna be on this channel, and that's when they're gonna need the right message at the right time. Got you. So then let's talk about and as I'm as I'm listening to you guys and I'm and I'm hearing

of the importance, how important this is and how much you can learn, what are some examples of insights that MSLs can attain from being a good social listener? So, you know, I can jump in here. I think thought leaders really are posting their their thoughts, their conversations, their research interests, their perspectives for everyone, to see, including their

colleagues. And and so I think, you know, some of the the key types of insights, you can learn. You can understand what their perceptions are on products, what they think of a clinical trial, that may be reading out soon or that just was completed, what they think about published data, whether that's from a congress or from a recent, publication that came out. What are their thoughts on that data? There's all kinds of, sentiment analysis you can do too around products and, and clinical

trials to get high level perceptions of what they might be thinking. And then, you know, they talk about their treatment, the treatment options, the treatment landscape, what they might consider first lines of of therapy, how they're sequencing, what the data gaps are. I think you can really learn learn a lot, and and sometimes there are polls on on, some of these social media platforms like x. They'll have polls. They have many ad boards, so you really have thought leaders responding to specific

questions, giving their opinions on treatment options, providing education. So I think you can learn a lot about, the HCP and what their what their thoughts are and, generally, what the, you know, the the HCPs in that space are are thinking, in general. Yep. Yep. And I wanna get back to I know one of you guys mentioned the conference preparation and planning strategy and how social listening can help with that.

But can you give some, a little more detail and insight as to what that would look like? I think, one of the cool things about social media is that, you know, what was there last year. Right? So I'm going into, you know, ash, 2024. I can look at 2023 and see when things got big, when things were happening, and who were the people there to know ahead of time who are the people they're gonna talk. So if one of my goals is to raise awareness about something happening, I know I wanna talk to those people because they were the ones making the voice last year.

And then the same point afterward, when you're listening for what just happened at the conference, when you do that, you know, when you're in that meeting in that conference, we know that most of those meetings are kind of a quick bump into. What better to say or say, hey. I saw that, you know, you have this opinion or you thought this on this trial. That doctor just thought that. He thought the need to share that. Bring that up to him. Dig in a little deeper. Take that insight and that nugget from social media and be able to expand that. And now you're bringing something to your company that even if they have internal social listening, they don't know because you were on the boots on the ground. You're just taking that and elevated your social listening to somewhere that the

headquarters team couldn't even do, providing even more value from those insights as an MSL. Awesome. So this all sounds great. And I feel like people are are enjoying this, taking notes, and saying, I have to do more of this. This is what I'm guessing from knowing my audience. But there's gotta be some guardrails. There's gotta be some words of caution that I would imagine MSLs need to hear. And so, Vandana, can you tell us what are what are some of the words of caution that you might

wanna share with the MSLs listening right now? Yeah. So first, just know what the company, what their guidance is, their general guidance, around social listing and engagement. I would be careful not to engage with HCPs, on their social channels or via social channels or patients, without getting clear guidance from your compliance, legal, and regulatory teams. There's quite a bit bit of variability across the industry with most companies, I think, tending to focus more on the listening as opposed to the engagement.

So before you engage with anybody on these social channels, make sure you've checked with your internal teams. And then, also, I I recently saw, some new draft guidance from the FDA that came out in July 2024 that talked about addressing misinformation online, and it was guidance for industry. So the policy established, was for tailored communications, that companies may voluntarily issue via the Internet to address any sort of misinformation, and social channels are really

susceptible to this to this misinformation. And so it does give you an opportunity or give gives companies an opportunity to determine how they want to, employ this guidance or if they wanna use it at all, but it will allow, companies to engage directly on social channels to ensure truthful information is available. So, again, discuss everything with your legal, right, and compliance teams, but I think these are some guardrails, that, at least, I've been thinking about recently. Yeah.

I mean, I think there there there's this tactful stalking thing. Right? There's this stalker tactful stalking that's happening, but if you overstep your bounds, it could it could be fatal. It could be bad. So I think what you said about listening more than engaging, I think, is just really good advice because that's the whole idea here. And I this is coming from someone who's who's very involved in social media, but from a

totally different standpoint. Totally different. I'm not an MSL. I don't pretend to be one. So that's why I asked because I've actually heard people getting themselves into trouble in the past. So I just wanted to mention it. But I know that there's so many other benefits to getting really good at this. And I think one of them, and I wanna ask you guys, from a scientific standpoint, staying ahead of new data, for example, how's that achieved through social listening, or can it be

achieved through social listening? Yeah. I think one of the big things to do, and I think a lot of people don't even know this, that you can create lists on Twitter x. So you can put all your HCPs there. You can put the key things you're looking to and then have a smaller work, you know, flow that you're following. And then once you're in there, you know the key hashtags because HCPs who are the true digital opinion leaders, those DOLs, they're using hashtag lymphoma, hashtag med twitter, hashtag etcetera in your disease state, and they're gonna do that every time. But then you'll see what's getting the most engagement when you click on that hashtag.

So not only will you know what's new, but you'll know what's most interesting to the people online. Awesome. Mindana, anything to add? Yeah. So there's a lot of buzz, you know, before data's data is released. So I think getting in on that, understanding what some of the HCP concerns are, maybe what data they're they're thinking about, can really help, prep for any of your meetings with with HCPs. Got you. And one one thing I want to turn to, I know we say in just a lot of time, you know, we're

stalking the HCPs, but all actuality, you're participating in their audience. Right? When you're following them and you're just the audience, you're not engaging in following those, you know, your company's policies, but you're in their audience. You wouldn't think it was stalking if your favorite HCP is at the conference and you sat in the audience. That's what you're doing except digitally. So you're making them happy. You're showing that you care about what they say even more so. Yeah. It's amazing how mainstream this is. Again, I know I talked about this before, but, I mean, this is this is a mandatory, I think, in this day and age in order to be successful and stay ahead of things.

But to to be even more, I guess, to focus on the technology and the technical aspect behind medical affairs, I it would I would be remiss if I didn't bring up gen AI or, you know, large language models in this conversation. So how do they play a part in social listening? Well, yeah, the technology is rapidly evolving. Every meeting, conference they go to, everyone's talking about, Gen AI and what it can do, and again, moving super fast.

But I think one of the good things and things that, these large language models do really well is summarization of text, and improving accuracy of sentiment. So with social listening, you can get a summary now pretty easily of your select HCPs, and what they think about a product or what they think about a trial. So I think that summarization can really help, move the needle forward where you get that overall sense of what's going on. Plus, you can obviously always go in and read individual, HCP insights, and you can also get

summaries of what a particular HCP thinks over 4 or 5, maybe x posts. Also, the sentiment analysis has improved dramatically. With these large language models, the accuracy is way better. So what are they thinking about a a specific product? Is it positive? Is it negative or a particular trial? So I think some of those things can really help, the MSLs as well as everybody else and and the HCPs too understand what's, what's going on.

And I do wanna take it a step further since, Stefan also mentioned omnichannel. One of the things you know, one of the data sources that you wanna use when you're trying to implement omnichannel, which many medical affairs organizations are at various stages, of this, is to try to incorporate different data sources into, a data lake. And so one of these data sources that's really important is what are is what HCPs are saying on, social, channels. So making sure that's incorporated, and then it gives you the ability now, also to more easily

analyze data across various channels. So, you know, you're you can bring in the 1 on 1 interaction that you've had. You can bring in the HCP insight and an advisory board. You now also have the social listing insight. So you're not looking at that data, maybe as siloed as you would, but really thinking about what the HCP is, saying overall across all channels or what, the community is saying. So I think those are some ways that, large language models could help. And another thing, that I've been thinking about kinda comes from the commercial side.

So they you know, you might hear this. It's sort of another buzzword. They talk about next right engagement. So kind of using, these tools to maybe give you a summary of what that HCP is thinking or maybe provide maybe even go as far as providing some suggestions. When you go for your meeting and you have your meeting with that HCP, here are some things to think about based on all of, what they're saying on these social channels. So it can be kind of a a helper, I think, a helper tool to to, provide you with some

additional information and insight before you go into your meeting. Love it. Awesome. So as I'm as I'm listening to you guys, I'm I'm starting to think that if MSLs can be consistent with this and can get really good at this, I would imagine it would give them a great advantage. I mean, is am I overstepping my bounds by saying that? And if so, like, what would the benefits and advantages be to somebody that gets really good at this? I think it's huge.

Not only is it a benefit to the MSL in building that relationship, and we mentioned about being in that audience knowing how to pre call plan, but you get really good at this. You're bringing back TA insights, especially if your company doesn't do this formally or if they don't do it formally for medical. You've now just shown yourself to be that extra, you know, that MSL who's bringing the most value back from that team. Right? Anyone we're all gonna bring insights and safely huge for all the MSLs, but if you're compiling the insights and digging deeper based on what's happening on social media, you're bringing back something special, something real time, and something that the teams may be

missing. So when they're asking, who do we pick for this event or who do we bring to this ad board? You gotta bring in that fact that, hey. You know, I we think he's a regional KOL from conferences, but look at this on dive and listening to him. He has people coat to coast sharing, commenting, agreeing. You can bring that, and you'll be sticking out both internally at the company, but also externally with your KOLs. Awesome. Vandana, anything to add? No. I think that's, that's well said. Definitely showing value, and also, you know, being able to act on, on these, on these

insights. Is this I mean, thinking through this, though, is this is this the same US versus global? Is is this or is there are there differences in, you know, in in our in US versus ex US? Yeah. I mean, I think there there are definitely some differences. One of the big ones is the channels. Channels differ across different regions and countries. If we look at the US, you're probably using x.

LinkedIn, Instagram, YouTube are probably some of the main ones, at least within the HCP community when they're speaking to each other. If you look at other countries, China uses WeChat, Weibo. You have, Line in other parts of Asia, and then also kind of what they focus on, which channels may be they may be more active in versus another. And as we talked about before, you really wanna meet that HCP where they are, so you wanna make sure that you're on the appropriate, appropriate channel.

And then also, there are guardrails for data privacy, data data protection, perspective. So that can influence how you might be able to, listen and what guardrails are in place there, based on those policies that different countries have. And I think another thing we've talked a lot about HCP, insights and and listening to HCPs, but some countries are also listening to patients. And, again, there are some guardrails there, but what are patients saying, via these social, platforms?

So I think that's another area that can be different, across regions. So When you say patients, are you talking MSLs? Or who who I'm I'm curious as to what you mean. Like, who's listening to the patients? Yeah. The MSLs are medical affairs. This is what patients are saying. Got you. So what you're saying is this because the whole time, we've been talking about, like, HCPs and KOLs, but that you bring up a good point. This is a good way to to get in touch with what the community is saying.

Yep. For sure. Interesting. So, Steph, I'll go back to you. Any any words any other words of advice? I I could imagine as I think about and I bring up the global aspect because I know there's a lot of people that listen to this show from different countries. But now I'm also thinking about what some of the other feedback or what I might hear from people. Like, yeah, Tom. That sounds great, but, like, when am I gonna have time to do that?

Or how do I incorporate that into my schedule? Or how does this affect my metrics or my KPIs? So can you talk a little bit about advice on how somebody can get good at this without, you know, maybe cannibalizing their their time or or or going down a rabbit hole? Yeah. Definitely. It doesn't need to be this giant thing at first. If, you know, first, see if your company has any resources that they're doing this already. Maybe they have a deal list and you can see are your KOLs on that list already.

2nd, start one step at a time. Right? This is you sticking out and providing extra value. No one's asking you to go through your entire, you know, AOL list in a day, in a week, in a month. You're gonna see all of them, hopefully, several times this year. Before each meeting, take 2 minutes and follow them and add that to that list. But the next your next meeting, they're already there. You don't have to go through the list, get there. And, you know, end of the day, a lot of us have been MSL. We know there's some downtime in airports. You know what you can do on your phone pretty easily?

You can go check an HCP out. Right? You don't have to sit there and try to go through your Viva notes and be squished on a plane. I'm a taller guy. I don't fit there. But you know what I can do all day? I can find someone else on Twitter. I can check out that new hashtag. You know, it takes 5 minutes a day is gonna make a huge difference because if they know no one else on your team is doing it, after a few months, you're gonna be there. Just like in MSL, people how do you compete with the top KOLs? You're reading an article 2 a week, which is more than most HCPs have time for. So similar to that, you'll become the next expert in that, be able to have pure exchanges

with the top DOLs on that side too. Great advice. Vandana, what about you? What's what last piece of advice would you have for for folks as it relates to this topic? Definitely not to ignore it. I think it's extremely valuable, hopefully, as you can see from this this podcast, and be involved. So even if it's only 5 minutes a day, start small, and also talk to your medical affairs leaders. Are they doing social listening? Is it something that they can centralize? Is it something that they can support you on?

Awesome. Guys, this was amazing. I I so appreciate you coming on here. I learned a lot. This is such a great topic, and I wanna, again, thank our sponsor, Medical Watch. Guys, don't forget to sign up. It's free. Medical.watch. I just love this conversation because it's it's novel, but it's it's not really novel because it's a thing. We just haven't really talked about it on this podcast. So thank you both for being here, and thank you guys all for listening. And as always, thank you for your support. If you got value in this, please share this episode with your other friends and colleagues

in medical affairs, and we will see you next time. Thank you so much for listening to the show. If you've enjoyed it, please subscribe so that you don't miss episodes in the future, and feel free to leave a rating or a review or a comment. Thanks again, and I look forward to seeing you again soon.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Wrong Voices: How Bad Mentors Can Ruin Your Career

    Nov 17, 202628 minVideo

    What qualifies someone to influence your future? Tom Caravela explains why career guidance should be filtered through relevant experience, current knowledge, credibility, and objectivity. He examines the risks of...

    Listen to the audio

    Credit the people on this episode

  2. Hidden Secret to Career Happiness and Longevity

    Nov 3, 202635 minVideo

    What turns an industry contact into a long-term ally? In this episode, Tom Caravela and Ed Doherty look beyond transactional networking to the genuine friendships that can shape a career in medical affairs. They discuss...

    Listen to the audio

    Credit the people on this episode

  3. How to AI-Proof Your Career: The 4 Pillars of Career Success

    Oct 20, 202623 minVideo

    Becoming undeniable is Tom Caravela’s answer to building career security in the age of AI. He breaks down four pillars you can control: skills, experience, relationships, and brand. Tom explains how continuous learning...

    Listen to the audio

    Credit the people on this episode

  4. How Medical Affairs Influences Decisions that Matter

    Oct 13, 202638 minVideo

    What happens after an MSL submits an insight? In this episode, Tom Caravela and Cameron Tew examine how field observations create value only when organizations decide what to do next. They discuss shared definitions,...

    Listen to the audio

    Credit the people on this episode

  5. Stop Being Your Own Worst Enemy

    Sep 29, 202619 minVideo

    In this episode, Tom Caravela discusses common mindset traps that can hold Medical Science Liaisons and aspiring MSLs back. He covers how to move past worst-case thinking, overanalysis, concern about others’ opinions,...

    Listen to the audio

    Credit the people on this episode